Novelix Pharmaceuticals Ltd — Important, 20-01-2026: Company Update

Novelix Pharmaceuticals' Board approved the allotment of 4 lakh equity shares at Rs. 20 each to non-promoter investors, following the conversion of warrants. These investors paid the remaining Rs. 15 per warrant, injecting Rs. 0.60 Cr into the company. This allotment increases the paid-up equity capital from Rs. 17.215 Cr to Rs. 17.615 Cr. The move provides fresh capital while incrementally diluting existing shareholders.